Tag: USNA

  • Drug Related Products: Natural Alternatives International (NASDAQ:NAII), ProPhase Labs (NASDAQ:PRPH), USANA Health Sciences (NYSE:USNA), Perrigo Company (NYSE:PRGO)

    Natural Alternatives International, Inc. (NAI) (NASDAQ:NAII), a leading formulator, manufacturer and marketer of customized nutritional supplements, announced yesterday the addition of Eugene M. Quast to lead its sales function as Vice President Global Sales. Natural Alternatives International, Inc. (NASDAQ:NAII) shares after opening at $5.35 moved to $5.35 on last trade day and at the end of the day closed at $5.35. Company price to sales ratio in past twelve months was calculated as 0.55 and price to cash ratio as 2.22. Natural Alternatives International, Inc. (NASDAQ:NAII) showed a positive weekly performance of 3.48%.

    ProPhase Labs, Inc. (NASDAQ:PRPH) yesterday reported a net sales increase of 5.8% to $9.6 million for the three months ended December 31, 2013 as compared to net sales of $9.1 million for the three months ended December 31, 2012. ProPhase Labs Inc. (NASDAQ:PRPH) shares advanced 5.82% in last trading session and ended the day on $2.00. PRPH return on equity ratio is recorded as 2.60% and its return on assets is 1.90%. ProPhase Labs Inc. (NASDAQ:PRPH) yearly performance is 13.64%.

    USANA Health Sciences, Inc. (NYSE:USNA) Net sales increased 10.7%, or $69.4 million, to $718.2 million in 2013, when compared with 2012. USANA Health Sciences, Inc. (NYSE:USNA) shares moved up 0.34% in last trading session and was closed at $73.77, while trading in range of $72.47 – $74.33. USANA Health Sciences, Inc. (NYSE:USNA) year to date (YTD) performance is -2.39%.

    Perrigo Company plc (NYSE:PRGO) on 26 march announced that its Nutritionals segment is partnering with KanPak LLC to manufacture store brand adult nutritional drinks comparable to Ensure® products. Perrigo Company (NYSE:PRGO) weekly performance is -6.07%. On last trading day company shares ended up $154.05. Perrigo Company (NYSE:PRGO) distance from 50-day simple moving average (SMA50) is -2.60%. Analysts mean target price for the company is $174.79.